Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessing treatment options for smokers with asthma.

Trial Profile

Assessing treatment options for smokers with asthma.

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2016

At a glance

  • Drugs Tiotropium bromide (Primary) ; Beta-adrenergic receptor agonists
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Jun 2013 Planned end date changed from 1 Jan 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
    • 10 Jan 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 10 Jun 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top